Previous close | 41.47 |
Open | 41.94 |
Bid | 41.62 x 100 |
Ask | 42.12 x 100 |
Day's range | 41.60 - 42.27 |
52-week range | 36.12 - 51.04 |
Volume | |
Avg. volume | 57,203 |
Market cap | 530.123M |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 31.01 |
EPS (TTM) | 1.35 |
Earnings date | 02 May 2024 |
Forward dividend & yield | 0.15 (0.36%) |
Ex-dividend date | 21 Dec 2023 |
1y target est | 62.50 |
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/
IRADIMED (NASDAQ:IRMD) has had a rough three months with its share price down 7.0%. But if you pay close attention, you...
WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at https://www.iradimed.com/investors/events. This ye